dipyridamole has been researched along with ticagrelor in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Björkman, JA; Glaves, P; Kirk, I; Sidaway, J; van Giezen, JJ | 1 |
| Cheng, Q; Coelho, PG; Cronstein, BN; Mediero, A; Reddy, VS; Tovar, N; Whatling, C; Wilder, T; Witek, L | 1 |
| Chern, Y; Ferré, S; Guitart, X | 1 |
| Dawood, BB; Hayes, J; Hoskins, HC; Protty, MB; Wilkins, SJ | 1 |
| Liu, S; Shah, J; Yu, W | 1 |
| Calderone, D; Capodanno, D; Scalia, L | 1 |
2 review(s) available for dipyridamole and ticagrelor
| Article | Year |
|---|---|
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor | 2022 |
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Factor XI; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor | 2022 |
4 other study(ies) available for dipyridamole and ticagrelor
| Article | Year |
|---|---|
Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model.
Topics: Acute Coronary Syndrome; Adenosine; Animals; Cell Line; Cell Line, Tumor; Coronary Circulation; Dipyridamole; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Hyperemia; Male; Purinergic P2Y Receptor Antagonists; Rats; Ticagrelor | 2012 |
Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism.
Topics: Adenosine; Animals; Blood Platelets; Bone Regeneration; Clopidogrel; Dipyridamole; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteogenesis; Platelet Activation; Receptor, Adenosine A2A; Ticagrelor; Ticlopidine | 2016 |
Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.
Topics: Age of Onset; Animals; Animals, Genetically Modified; Biomarkers; Brain; Carrier Proteins; Corpus Striatum; Dilazep; Dipyridamole; Disease Models, Animal; Disease Progression; Equilibrative Nucleoside Transporter 1; Humans; Huntingtin Protein; Huntington Disease; Mice; Neurons; Rats; Receptor, Adenosine A2A; Ticagrelor | 2017 |
Prescribing patterns of oral antiplatelets in Wales: evolving trends from 2005 to 2016.
Topics: Administration, Oral; Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Retrospective Studies; Ticagrelor; Wales | 2018 |